Gianluca Gaïdano

1989–2026 年に発表

別表記
Gianluca Gaidano
258
論文数
35,778
被引用数
111
h 指数
249
i10 指数

被引用数

Gianluca Gaïdano の年別被引用数1990 年: 被引用 2 件1991 年: 被引用 9 件1992 年: 被引用 27 件1993 年: 被引用 55 件1994 年: 被引用 44 件1995 年: 被引用 67 件1996 年: 被引用 56 件1997 年: 被引用 53 件1998 年: 被引用 88 件1999 年: 被引用 122 件2000 年: 被引用 112 件2001 年: 被引用 104 件2002 年: 被引用 127 件2003 年: 被引用 126 件2004 年: 被引用 70 件2005 年: 被引用 97 件2006 年: 被引用 71 件2007 年: 被引用 104 件2008 年: 被引用 78 件2009 年: 被引用 95 件2010 年: 被引用 101 件2011 年: 被引用 166 件2012 年: 被引用 255 件2013 年: 被引用 286 件2014 年: 被引用 286 件2015 年: 被引用 276 件2016 年: 被引用 345 件2017 年: 被引用 338 件2018 年: 被引用 313 件2019 年: 被引用 1,069 件2020 年: 被引用 1,247 件2021 年: 被引用 1,279 件2022 年: 被引用 1,036 件2023 年: 被引用 735 件2024 年: 被引用 1,078 件2025 年: 被引用 499 件2026 年: 被引用 15 件

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 3,500 件、この内訳の 24%イタリア: 引用元論文 1,345 件、この内訳の 9.2%イギリス: 引用元論文 1,023 件、この内訳の 7%ドイツ: 引用元論文 1,000 件、この内訳の 6.9%フランス: 引用元論文 811 件、この内訳の 5.6%中国: 引用元論文 745 件、この内訳の 5.1%スペイン: 引用元論文 674 件、この内訳の 4.6%カナダ: 引用元論文 473 件、この内訳の 3.3%スイス: 引用元論文 467 件、この内訳の 3.2%オランダ: 引用元論文 374 件、この内訳の 2.6%オーストラリア: 引用元論文 371 件、この内訳の 2.5%日本: 引用元論文 288 件、この内訳の 2%
0%24%その他 24%

分野

  • Medicine76.6%
  • Biochemistry, Genetics and Molecular Biology18.1%
  • Immunology and Microbiology3.9%
  • Neuroscience0.3%
  • Computer Science0.2%
  • Economics, Econometrics and Finance0.1%
  • その他0.8%

トピック

  • Lymphoma Diagnosis and Treatment12.3%
  • Chronic Lymphocytic Leukemia Research8.9%
  • Viral-associated cancers and disorders4%
  • CAR-T cell therapy research3.3%
  • Acute Myeloid Leukemia Research2.7%
  • Multiple Myeloma Research and Treatments2.6%
  • その他66.2%

共著者

全論文

検索で開く
  1. Enhanced detection of minimal residual disease by targeted sequencing of phased variants in circulating tumor DNA

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Biotechnology 2021 被引用: 366

  2. Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Fong Clow, Lori Styles, Danelle F. James, Thomas J. Kipps - New England Journal of Medicine 2015 被引用: 1,562

  3. Tafasitamab plus lenalidomide in relapsed or refractory diffuse large B-cell lymphoma (L-MIND): a multicentre, prospective, single-arm, phase 2 study

    著者: , , , , , , , , , , , , , , , , - The Lancet Oncology 2020 被引用: 519

  4. Circulating Tumor DNA Measurements As Early Outcome Predictors in Diffuse Large B-Cell Lymphoma

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2018 被引用: 496

  5. Dynamic Risk Profiling Using Serial Tumor Biomarkers for Personalized Outcome Prediction

    著者: , , , , , , , , , , , , , , , , , , , , , , - Cell 2019 被引用: 239

  6. Effect of Recombinant Zoster Vaccine on Incidence of Herpes Zoster After Autologous Stem Cell Transplantation

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , for the ZOE-HSCT Study Group Collaborators - JAMA 2019 被引用: 257

  7. Immunogenicity and safety of the adjuvanted recombinant zoster vaccine in adults with haematological malignancies: a phase 3, randomised, clinical trial and post-hoc efficacy analysis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Norbert Blesing, Terrance Comeau, Teresa del Campo, Patricia Disperati, Richard Eek, Hyeon‐Seok Eom, Gianluca Gaïdano, Sebastian Grosicki, Thierry Guillaume, Wojciech Homenda, William Ying Khee Hwang, Nikolay Ilyin, Anna Johnston, Seok Jin Kim, Ching-Yuan Kuo, А Ю Кувшинов, Dong‐Gun Lee, Jae Hoon Lee, Je‐Jung Lee, Stéphane Leprêtre, Albert Kwok-Wai Lie, Alessandro Lucchesi, Ahmed Ijaz Masood, Naheed Mir, Anna Carolina Miranda Castillo, Kathleen M. Mullane, Alexandr Myasnikov, Raquel Oña Navarrete, Karlis Pauksens, Andrew Peniket, Jaime Pérez de Oteyza, David Pohlreich, Humphrey Pullon, Philippe Quittet, Philippe Rodon, Lars Rombo, Olga Samoylova, Johan Berglund, Ariah Schattner, Dominik Selleslag, Marjatta Sinisalo, Faisal Sultan, Koen Theunissen, Paul Turner, Po-Nan Wang, Lucrecia Yáñez San Segundo, Jo‐Anne H. Young, Pierre Zachée, Francesco Zaja - The Lancet Infectious Diseases 2019 被引用: 254

  8. Circulating tumor DNA reveals genetics, clonal evolution, and residual disease in classical Hodgkin lymphoma

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Franco Cavalli, Emanuele Zucca, Luigi Maria Larocca, Gianluca Gaïdano, Stefan Hohaus, Carmelo Carlo‐Stella, Davide Rossi - Blood 2018 被引用: 338

  9. Detection of early seeding of Richter transformation in chronic lymphocytic leukemia

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Francesc Bosch, Marta Aymerich, Anna Enjuanes, Sílvia Ruiz-Gaspà, Armando López‐Guillermo, Pedro Jares, Sı́lvia Beà, Salvador Capella-Gutiérrez, Josep Lluis Gelpí, Núria López-Bigas, David Torrents, Peter J. Campbell, Marta Gut, Davide Rossi, Gianluca Gaïdano, Xosé S. Puente, Pablo M. García-Rovés, Dolors Colomer, Holger Heyn, Francesco Maura, José I. Martín‐Subero, Elı́as Campo - Nature Medicine 2022 被引用: 135

  10. Inactivating mutations of acetyltransferase genes in B-cell lymphoma

    著者: , , , , , , , , , , , , , , , , , - Nature 2011 被引用: 942

  11. Genetics of Follicular Lymphoma Transformation

    著者: , , , , , , , , , , , , , , , , , , - Cell Reports 2014 被引用: 585

  12. BTK and PLCG2 remain unmutated in one-third of patients with CLL relapsing on ibrutinib

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Renata Walewska, Anders Österborg, Diego Cortese, Pamela Ranghetti, Panagiotis Baliakas, Κώστας Σταματόπουλος, Lydia Scarfò, Richard W. Rosenquist, Paolo Ghia - Blood Advances 2023 被引用: 66

  13. Gemtuzumab Ozogamicin Versus Best Supportive Care in Older Patients With Newly Diagnosed Acute Myeloid Leukemia Unsuitable for Intensive Chemotherapy: Results of the Randomized Phase III EORTC-GIMEMA AML-19 Trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2016 被引用: 348

  14. Genetic mechanisms of HLA-I loss and immune escape in diffuse large B cell lymphoma

    著者: , , , , , , , , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2021 被引用: 93

  15. Carfilzomib and dexamethasone versus bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma (ENDEAVOR): a randomised, phase 3, open-label, multicentre study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Wee Joo Chng - The Lancet Oncology 2015 被引用: 849

  16. The genetics of Richter syndrome reveals disease heterogeneity and predicts survival after transformation

    著者: , , , , , , , , , , , , , , , , , , , , , , , , - Blood 2011 被引用: 377

  17. Diffuse large B-cell lymphoma genotyping on the liquid biopsy

    著者: , , , , , , , , , , , , , , - Blood 2017 被引用: 258

  18. Analysis of the coding genome of diffuse large B-cell lymphoma

    著者: , , , , , , , , , , , , , , , , - Nature Genetics 2011 被引用: 963

  19. Short Diagnosis-to-Treatment Interval Is Associated With Higher Circulating Tumor DNA Levels in Diffuse Large B-Cell Lymphoma

    著者: , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2021 被引用: 78

  20. Convergent Mutations and Kinase Fusions Lead to Oncogenic STAT3 Activation in Anaplastic Large Cell Lymphoma

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Gianluca Gaïdano, Stefano Pileri, Enrico Tiacci, Brunangelo Falini, Leonard D. Shultz, Laurence Mévellec, Jorge Vialard, Roberto Piva, Francesco Bertoni, Raúl Rabadán, Giorgio Inghirami - Cancer Cell 2015 被引用: 442

  21. Infections by carbapenem-resistant Klebsiella pneumoniae in SCT recipients: a nationwide retrospective survey from Italy

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Attilio Rovelli, Clara Pecoraro, Alessandro Busca, Francesca Carraro, Franca Fagioli, Susanna Gallo, Daniele Caravelli, Marco De Gobbi, Giuseppe Saglio, Claudia Castellino, Nicola Mordini, Gianluca Gaïdano, Luca Nassi, R Raimondi, Michele Vespignani, Anna Maria Scattolin, Irene Sara Panizzolo, Simone Cesaro, Anna Candoni, Francesca Patriarca, Andrea Bacigalupo, Anna Maria Raiola, Elio Castagnola, Edoardo Lanino, Marta Stanzani, Giuseppe Bandini, Erika Massaccesi, Arcangelo Prete, Simona Bassi, Daniele Vallisa, Cecilia Caramatti, Franco Aversa, Eliana Zuffa, Stefano Guidi, Alberto Bosi, Veronica Tintori, Anna Paola Iori, Saveria Capria, Laura Cudillo, William Arcese, Teresa Dentamaro, Paolo de Fabritiis, Barbara Anaclerico, Anna Chierichini, Monica Piedimonte, Antonella Ferrari, Francesco Marchesi, Andrea Mengarelli, Elisabetta Cerchiara, Maria Cristina Tirindelli, Javid Gaziev, Alessandro Severino, Ignazio Majolino, Patrizia Chiusolo, Simona Sica, Alice Bertaina, Barbarella Lucarelli, Maria Speranza Massei, Alessandra Carotti, Katia Perruccio, Maurizio Caniglia, Stella Santarone, Paolo Di Bartolomeo, Serena Mazzotta, Piero Galieni, Attilio Olivieri, Gennaro De Rosa, Antonio M. Risitano, Mario Delia, Giorgina Specchia ほか 12 名 - Bone Marrow Transplantation 2014 被引用: 188

  22. Results from a phase I/II trial of cusatuzumab combined with azacitidine in patients with newly diagnosed acute myeloid leukemia who are ineligible for intensive chemotherapy

    著者: , , , , , , , , , , , , , , , , , , , - Haematologica 2023 被引用: 35

  23. Clinical heterogeneity and predictors of outcome in primary autoimmune hemolytic anemia: a GIMEMA study of 308 patients

    著者: , , , , , , , , , , , , , , , , , , , , , , , - Blood 2014 被引用: 372

  24. Long-term outcomes from the Phase II L-MIND study of tafasitamab (MOR208) plus lenalidomide in patients with relapsed or refractory diffuse large B-cell lymphoma

    著者: , , , , , , , , , , , , , , , , , , , , - Haematologica 2021 被引用: 140